GRUNELABS = INNOVATION
The objective of GrüneLabs is the production of special medicines to treat neurological diseases and other pathologies.
We are located in Uruguay and Portugal
WHO WE ARE
GrüneLabs is a pharmaceutical laboratory which seeks innovation in the processing of botanical specialties for the production of medicines with high technology, for children, adult and veterinary uses.
We combine biotechnology and pharmaceuticals to achieve high quality products.
The innovative merit of the project is the procurement of cannabis oils for the treatment of various diseases.
To generate an extract that serves as raw material for the development of medicinal products.
Meroflex is a highly standardized pharmaceutical product derived from two chemovars of Cannabis sativa, predominantly CBD in a ratio of 2: 1 to THC.
MEET OUR TEAM
João Paulo Rocha has expertise in designing and building complex high-tech but functional and profitable industrial structures for the pharmaceutical industry specialized in cannabis.
Currently under construction and subsequent management of another GruneLabs laboratory with a capacity 10 times higher than the previous one in Portugal, he spends his free time studying the benefits of the plant and the new technologies for cultivation, extraction and processing of pharmaceutical and cosmetic products.
One of the pioneering entrepreneurs in the medical cannabis industry in Uruguay. Partner and CEO of the Grunelabs Group.